Get started
Author

Dai Kakiuchi

HP1γ links histone methylation marks to meiotic synapsis in mice
2011 · Yuki Takada, Chie Naruse, et al. · Development · 82
PDF
A novel gene trapping for identifying genes expressed under the control of specific transcription factors
2007 · Chie Naruse, Yoshiyasu Fukusumi, et al. · Biochemical and Biophysical Research Communications · 25
Oscillatory potentials in electroretinogram as an early marker of visual abnormalities in vitamin A deficiency
2014 · DAI KAKIUCHI, TAISUKE UEHARA, et al. · Molecular Medicine Reports · 13
PDF
Discovery of a potent and selective Axl inhibitor in preclinical model
2021 · Satoshi Inoue, Yoshinobu Yamane, et al. · Bioorganic & Medicinal Chemistry · 12
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
2025 · Yuta Suzuki, Takayuki Miyazaki, et al. · Molecular Therapy — Nucleic Acids · 9
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors
2021 · Satoshi Inoue, Yoshinobu Yamane, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Combination of circulating microRNAs as indicators of specific targets of retinal toxicity in rats
2018 · Dai Kakiuchi, Yoshikazu Taketa, et al. · Toxicology · 7
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2022 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al. · Molecular Cancer Therapeutics · 5
Malaria in cynomolgus monkeys used in toxicity studies in Japan
2015 · Etsuko Ohta, Yuko Nagayama, et al. · Journal of Toxicologic Pathology · 4
PDF
Whole genome mutagenicity evaluation using Hawk-Seq™ demonstrates high inter-laboratory reproducibility and concordance with the transgenic rodent gene mutation assay
2025 · Shoji Matsumura, Sayaka Hosoi, et al. · Genes and Environment · 3
PDF
Assessment of chronic toxicity study designs and development of a weight-of-evidence-based decision-making model for biopharmaceuticals: A survey of Japanese pharmaceutical companies
2026 · Yui Suzuki, Tetsuo Aida, et al. · Regulatory Toxicology and Pharmacology · 1
Supplementary Figures S1-S7 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
PDF
Supplementary Table S2 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S5 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S3 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S1 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S4 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2025 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Structure-mutagenicity relationships on quinoline and indole analogues in the Ames test
2024 · Masaki Kurakami, Atsushi Hakura, et al. · Genes and Environment
PDF
Data from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2024 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S3 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Figures S1-S7 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S4 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S1 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S2 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Supplementary Table S5 from ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
2023 · Shuntaro Tsukamoto, Naoko Hata Sugi, et al.
Works count: 36
Citation count: 170
H-index: 7
I10-index: 4
Year
Topic
Type